Synthesis and biological evaluation of new clofibrate analogues as potential PPARα agonists
…, E Santandrea, N Dell'Uomo, F Giannessi…
Index: Perrone, Maria Grazia; Santandrea, Ernesto; Dell'Uomo, Natalina; Giannessi, Fabio; Milazzo, Ferdinando Maria; Sciarroni, Anna Floriana; Scilimati, Antonio; Tortorella, Vincenzo European Journal of Medicinal Chemistry, 2005 , vol. 40, # 2 p. 143 - 154
Full Text: HTML
Citation Number: 19
Abstract
Clofibrate is a lipid-profile modifying agent belonging to the fibrate class of drugs. Fibrates are known to exhibit their beneficial effects by activating peroxisome proliferator-activated receptor-α (PPARα) and used in the treatment of dyslipidemia and atherosclerosis and for the prevention of heart failure. Hereby, the preparation of two new sets of clofibrate analogues, ethyl 2-(4-chlorophenoxy)-3-oxoalkanoates and ethyl 2-(4-chlorophenoxy)-3- ...
Related Articles:
[Redondo, Jordi; Sanchez-Ferrando, Francisco; Valls, Montserrat; Virgili, Albert Magnetic Resonance in Chemistry, 1988 , vol. 26, p. 511 - 517]